NPCE
Neuropace IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$576.87M
P/E Ratio
—
EPS
$-0.65
Beta
1.93
52W High
$19.60
52W Low
$7.56
50-Day MA
$15.43
200-Day MA
$13.63
Dividend Yield
—
Profit Margin
-21.70%
Forward P/E
—
PEG Ratio
—
About Neuropace Inc
NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
Fundamentals
| Revenue (TTM) | $99.53M |
| Gross Profit (TTM) | $77.93M |
| EBITDA | $-16.51M |
| Operating Margin | -25.20% |
| Return on Equity | -111.40% |
| Return on Assets | -10.00% |
| Revenue/Share (TTM) | $2.99 |
| Book Value | $0.57 |
| Price-to-Book | 39.82 |
| Price-to-Sales (TTM) | 5.80 |
| EV/Revenue | 5.95 |
| EV/EBITDA | -16.94 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.00% |
| Shares Outstanding | $34.09M |
| Float | $23.36M |
| % Insiders | 3.99% |
| % Institutions | 96.30% |
Historical Volatility
HV 10-Day
90.06%
HV 20-Day
74.71%
HV 30-Day
64.70%
HV 60-Day
54.13%
HV Rank
73.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($20.00 target)
1
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026